Human Gene Module / Chromosome 16 / CNOT1

CNOT1CCR4-NOT transcription complex subunit 1

SFARI Gene Score
2S
Strong Candidate, Syndromic Criteria 2.1, Syndromic
Autism Reports / Total Reports
3 / 9
Rare Variants / Common Variants
42 / 0
Aliases
CNOT1, AD-005,  CDC39,  HPE12,  NOT1,  NOT1H
Associated Syndromes
Vissers-Bodmer syndrome
Chromosome Band
16q21
Associated Disorders
DD/NDD, ASD, EP, EPS
Relevance to Autism

A de novo missense variant that was predicted to be damaging was identified in the CNOT1 gene in an ASD proband from the Simons Simplex Collection (Iossifov et al., 2014). A recurrent missense variant in CNOT1 (p.Arg535Cys) has been found to result in holoprosencephaly-12 with or without pancreatic agenesis, a developmental disorder characterized by abnormal separation of the embryonic forebrain resulting in dysmorphic facial features and often, but not always, impaired neurologic development (Kruszka et al., 2019; De Franco et al., 2019). Vissers et al., 2020 reported on 39 individuals with CNOT1 variants (34 previously unreported cases and the 5 cases previously described in Kruszka et al., 2019 and De Franco et al., 2019) who presented with a clinical spectrum of intellectual disability, motor delay, speech delay, seizures, hypotonia, and behavioral problems; of the 32 individuals assessed for behavioral abnormalities, 9 presented with autism spectrum disorder.

Molecular Function

Scaffolding component of the CCR4-NOT complex which is one of the major cellular mRNA deadenylases and is linked to various cellular processes including bulk mRNA degradation, miRNA-mediated repression, translational repression during translational initiation and general transcription regulation. Additional complex functions may be a consequence of its influence on mRNA expression. Its scaffolding function implies its interaction with the catalytic complex module and diverse RNA-binding proteins mediating the complex recruitment to selected mRNA 3'UTRs. Involved in degradation of AU-rich element (ARE)-containing mRNAs probably via association with ZFP36. Mediates the recruitment of the CCR4-NOT complex to miRNA targets and to the RISC complex via association with TNRC6A, TNRC6B or TNRC6C. Acts as a transcriptional repressor. Represses the ligand-dependent transcriptional activation by nuclear receptors. Involved in the maintenance of embryonic stem (ES) cell identity.

SFARI Genomic Platforms
Reports related to CNOT1 (9 Reports)
# Type Title Author, Year Autism Report Associated Disorders
1 Primary The contribution of de novo coding mutations to autism spectrum disorder Iossifov I et al. (2014) Yes -
2 Support Meta-analysis of 2,104 trios provides support for 10 new genes for intellectual disability Lelieveld SH et al. (2016) No -
3 Support A CCR4-NOT Transcription Complex, Subunit 1, CNOT1, Variant Associated with Holoprosencephaly Kruszka P et al. (2019) No DD
4 Support A Specific CNOT1 Mutation Results in a Novel Syndrome of Pancreatic Agenesis and Holoprosencephaly through Impaired Pancreatic and Neurological Development De Franco E et al. (2019) No Epilepsy/seizures
5 Recent Recommendation De Novo Variants in CNOT1, a Central Component of the CCR4-NOT Complex Involved in Gene Expression and RNA and Protein Stability, Cause Neurodevelopmental Delay Vissers LELM et al. (2020) No ASD
6 Support - Bertoli-Avella AM et al. (2021) No -
7 Support - Bruno LP et al. (2021) Yes -
8 Support - Zhou X et al. (2022) Yes -
9 Support - et al. () No -
Rare Variants   (42)
Status Allele Change Residue Change Variant Type Inheritance Pattern Parental Transmission Family Type PubMed ID Author, Year
- - copy_number_loss De novo - - 32553196 Vissers LELM et al. (2020)
c.7011C>G p.Phe2337Leu missense_variant De novo - Simplex 38041506 et al. ()
c.76C>T p.Arg26Ter stop_gained De novo - - 32553196 Vissers LELM et al. (2020)
c.97C>T p.Gln33Ter stop_gained De novo - - 32553196 Vissers LELM et al. (2020)
- - copy_number_loss De novo - Simplex 33875846 Bertoli-Avella AM et al. (2021)
c.210+1G>T - splice_site_variant De novo - - 32553196 Vissers LELM et al. (2020)
c.2236A>C p.Thr746Pro missense_variant De novo - - 35982159 Zhou X et al. (2022)
c.3735+1G>T - splice_site_variant De novo - - 32553196 Vissers LELM et al. (2020)
c.3735+5G>A - splice_site_variant De novo - - 32553196 Vissers LELM et al. (2020)
c.4138-2A>C - splice_site_variant De novo - - 32553196 Vissers LELM et al. (2020)
c.5914G>A p.Gly1972Arg missense_variant De novo - - 35982159 Zhou X et al. (2022)
c.582A>G p.Gly194%3D synonymous_variant De novo - - 35982159 Zhou X et al. (2022)
c.777G>C p.Met259Ile synonymous_variant De novo - - 35982159 Zhou X et al. (2022)
c.1188T>A p.Tyr396Ter stop_gained Unknown - - 32553196 Vissers LELM et al. (2020)
c.1603C>T p.Arg535Cys missense_variant De novo - - 31006510 Kruszka P et al. (2019)
c.1924C>G p.Gln642Glu missense_variant De novo - - 32553196 Vissers LELM et al. (2020)
c.2689G>A p.Glu897Lys missense_variant De novo - - 32553196 Vissers LELM et al. (2020)
c.2698C>T p.Arg900Cys missense_variant De novo - - 32553196 Vissers LELM et al. (2020)
c.76C>T p.Arg26Ter stop_gained Familial Maternal - 32553196 Vissers LELM et al. (2020)
c.3113C>T p.Thr1038Ile missense_variant De novo - - 32553196 Vissers LELM et al. (2020)
c.3265G>C p.Val1089Leu missense_variant De novo - - 32553196 Vissers LELM et al. (2020)
c.3443T>C p.Leu1148Pro missense_variant De novo - - 32553196 Vissers LELM et al. (2020)
c.3563A>G p.Asp1188Gly missense_variant De novo - - 32553196 Vissers LELM et al. (2020)
c.3722A>G p.Lys1241Arg missense_variant De novo - - 32553196 Vissers LELM et al. (2020)
c.4255A>G p.Thr1419Ala missense_variant De novo - - 32553196 Vissers LELM et al. (2020)
c.4283T>C p.Phe1428Ser missense_variant De novo - - 32553196 Vissers LELM et al. (2020)
c.4432C>T p.Arg1478Cys missense_variant De novo - - 32553196 Vissers LELM et al. (2020)
c.4482A>T p.Gln1494His missense_variant De novo - - 32553196 Vissers LELM et al. (2020)
c.4714T>G p.Tyr1572Asp missense_variant De novo - - 32553196 Vissers LELM et al. (2020)
c.6647A>G p.Asn2216Ser missense_variant De novo - - 32553196 Vissers LELM et al. (2020)
c.102+2T>C - splice_site_variant Familial Maternal - 32553196 Vissers LELM et al. (2020)
c.1804A>G p.Thr602Ala missense_variant De novo - Simplex 34948243 Bruno LP et al. (2021)
c.4800G>C p.Lys1600Asn splice_site_variant De novo - - 32553196 Vissers LELM et al. (2020)
c.2636C>G p.Ser879Cys missense_variant De novo - Simplex 25363768 Iossifov I et al. (2014)
c.1603C>T p.Arg535Cys missense_variant De novo - Simplex 31006513 De Franco E et al. (2019)
c.2698C>T p.Arg900Cys missense_variant De novo - Simplex 27479843 Lelieveld SH et al. (2016)
c.6303dup p.Leu2102SerfsTer4 frameshift_variant De novo - - 32553196 Vissers LELM et al. (2020)
c.608_611del p.Ile203ThrfsTer32 frameshift_variant De novo - - 32553196 Vissers LELM et al. (2020)
c.1603C>T p.Arg535Cys missense_variant Unknown Not paternal Simplex 31006513 De Franco E et al. (2019)
c.3363_3364insTAAGGTAAGCTAAA p.Val1122Ter frameshift_variant De novo - - 32553196 Vissers LELM et al. (2020)
c.3681_3687del p.Lys1227AsnfsTer7 frameshift_variant Unknown Not paternal - 32553196 Vissers LELM et al. (2020)
c.6518_6519insAAACAAAAAGGATTTGGATTCCTATCTTA p.Asp2174AsnfsTer71 frameshift_variant Familial Maternal - 32553196 Vissers LELM et al. (2020)
Common Variants  

No common variants reported.

SFARI Gene score
2S

Strong Candidate, Syndromic

Score Delta: Score remained at 2S

2

Strong Candidate

See all Category 2 Genes

We considered a rigorous statistical comparison between cases and controls, yielding genome-wide statistical significance, with independent replication, to be the strongest possible evidence for a gene. These criteria were relaxed slightly for category 2.

The syndromic category includes mutations that are associated with a substantial degree of increased risk and consistently linked to additional characteristics not required for an ASD diagnosis. If there is independent evidence implicating a gene in idiopathic ASD, it will be listed as "#S" (e.g., 2S, 3S, etc.). If there is no such independent evidence, the gene will be listed simply as "S."

4/1/2022
icon
2

Increased from to 2

Krishnan Probability Score

Score 0.44548167526154

Ranking 15387/25841 scored genes


[Show Scoring Methodology]
Krishnan and colleagues generated probability scores genome-wide by using a machine learning approach on a human brain-specific gene network. The method was first presented in Nat Neurosci 19, 1454-1462 (2016), and scores for more than 25,000 RefSeq genes can be accessed in column G of supplementary table 3 (see: http://www.nature.com/neuro/journal/v19/n11/extref/nn.4353-S5.xlsx). A searchable browser, with the ability to view networks of associated ASD risk genes, can be found at asd.princeton.edu.
ExAC Score

Score 0.99999999999948

Ranking 40/18225 scored genes


[Show Scoring Methodology]
The Exome Aggregation Consortium (ExAC) is a summary database of 60,706 exomes that has been widely used to estimate 'constraint' on mutation for individual genes. It was introduced by Lek et al. Nature 536, 285-291 (2016), and the ExAC browser can be found at exac.broadinstitute.org. The pLI score was developed as measure of intolerance to loss-of- function mutation. A pLI > 0.9 is generally viewed as highly constrained, and thus any loss-of- function mutations in autism in such a gene would be more likely to confer risk. For a full list of pLI scores see: ftp://ftp.broadinstitute.org/pub/ExAC_release/release0.3.1/functional_gene_constraint/fordist_cle aned_exac_nonTCGA_z_pli_rec_null_data.txt
Sanders TADA Score

Score 0.92439440627899

Ranking 9980/18665 scored genes


[Show Scoring Methodology]
The TADA score ('Transmission and De novo Association') was introduced by He et al. PLoS Genet 9(8):e1003671 (2013), and is a statistic that integrates evidence from both de novo and transmitted mutations. It forms the basis for the claim of 65 individual genes being strongly associated with autism risk at a false discovery rate of 0.1 (Sanders et al. Neuron 87, 1215-1233 (2015)). The calculated TADA score for 18,665 RefSeq genes can be found in column P of Supplementary Table 6 in the Sanders et al. paper (the column headed 'tadaFdrAscSscExomeSscAgpSmallDel'), which represents a combined analysis of exome data and small de novo deletions (see www.cell.com/cms/attachment/2038545319/2052606711/mmc7.xlsx).
Zhang D Score

Score 0.50851609511812

Ranking 458/20870 scored genes


[Show Scoring Methodology]
The DAMAGES score (disease-associated mutation analysis using gene expression signatures), or D score, was developed to combine evidence from de novo loss-of- function mutation with evidence from cell-type- specific gene expression in the mouse brain (specifically translational profiles of 24 specific mouse CNS cell types isolated from 6 different brain regions). Genes with positive D scores are more likely to be associated with autism risk, with higher-confidence genes having higher D scores. This statistic was first presented by Zhang & Shen (Hum Mutat 38, 204- 215 (2017), and D scores for more than 20,000 RefSeq genes can be found in column M in supplementary table 2 from that paper.
Submit New Gene

Report an Error